ATE296098T1 - USE OF TOPIRAMATE FOR THE TREATMENT AND DIAGNOSIS OF BREATHING DISORDERS DURING SLEEP AND MEANS OF CARRYING OUT TREATMENT AND DIAGNOSIS - Google Patents

USE OF TOPIRAMATE FOR THE TREATMENT AND DIAGNOSIS OF BREATHING DISORDERS DURING SLEEP AND MEANS OF CARRYING OUT TREATMENT AND DIAGNOSIS

Info

Publication number
ATE296098T1
ATE296098T1 AT01904764T AT01904764T ATE296098T1 AT E296098 T1 ATE296098 T1 AT E296098T1 AT 01904764 T AT01904764 T AT 01904764T AT 01904764 T AT01904764 T AT 01904764T AT E296098 T1 ATE296098 T1 AT E296098T1
Authority
AT
Austria
Prior art keywords
diagnosis
treatment
topiramate
sleep
carrying
Prior art date
Application number
AT01904764T
Other languages
German (de)
Inventor
Jan Hedner
Ludger Grote
Lars Sjoestroem
Kaj Stenloef
Original Assignee
Jan Hedner
Ludger Grote
Lars Sjoestroem
Kaj Stenloef
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jan Hedner, Ludger Grote, Lars Sjoestroem, Kaj Stenloef filed Critical Jan Hedner
Application granted granted Critical
Publication of ATE296098T1 publication Critical patent/ATE296098T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Endoscopes (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Radiation-Therapy Devices (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

A method for treating snoring, sleep apnoea and other forms of sleep disordered breathing involves administration to a patient of a therapeutically effective amount of topiramate over an appropriate period of time, such as a period substantially coinciding with the sleep period of a patient. A useful route of administration is per os. Also disclosed is the use of topiramate for the diagnosis of snoring, sleep apnoea and other forms of sleep disordered breathing.
AT01904764T 2000-02-24 2001-02-14 USE OF TOPIRAMATE FOR THE TREATMENT AND DIAGNOSIS OF BREATHING DISORDERS DURING SLEEP AND MEANS OF CARRYING OUT TREATMENT AND DIAGNOSIS ATE296098T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0000601A SE0000601D0 (en) 2000-02-24 2000-02-24 Methods to treat and diagnose respiratory disorders in sleep and agents to perform the procedure
PCT/SE2001/000315 WO2001062243A1 (en) 2000-02-24 2001-02-14 Method of treating and diagnosing sleep disordered breathing and means for carrying out the method

Publications (1)

Publication Number Publication Date
ATE296098T1 true ATE296098T1 (en) 2005-06-15

Family

ID=20278571

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01904764T ATE296098T1 (en) 2000-02-24 2001-02-14 USE OF TOPIRAMATE FOR THE TREATMENT AND DIAGNOSIS OF BREATHING DISORDERS DURING SLEEP AND MEANS OF CARRYING OUT TREATMENT AND DIAGNOSIS

Country Status (13)

Country Link
US (1) US7981443B2 (en)
EP (1) EP1261333B1 (en)
JP (1) JP4896334B2 (en)
AT (1) ATE296098T1 (en)
AU (2) AU3258801A (en)
CA (1) CA2401000C (en)
DE (1) DE60111025T2 (en)
DK (1) DK1261333T3 (en)
ES (1) ES2243444T3 (en)
NZ (1) NZ520781A (en)
PT (1) PT1261333E (en)
SE (1) SE0000601D0 (en)
WO (1) WO2001062243A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2461539A1 (en) * 2001-09-24 2003-04-03 Faruk S. Abuzzahab, Sr. Anticonvulsant derivatives useful for the treatment of restless limb syndrome and periodic limb movement disorder
SE0400378D0 (en) 2004-02-17 2004-02-17 Jan Hedner Methods to treat and diagnose respiratory disorders in sleep and agents to perform the procedure
CA2622721A1 (en) * 2005-09-16 2007-03-22 Cereuscience Ab Method and means of preventing and treating sleep disordered breathing
WO2007098202A2 (en) 2006-02-16 2007-08-30 Imthera Medical, Inc. An rfid based apparatus, system, and method for therapeutic treatment of a patient
WO2008025148A1 (en) * 2006-08-31 2008-03-06 The Governors Of The University Of Alberta Method of inhibition of respiratory depression using positive allosteric ampa receptor modulators
US9744137B2 (en) * 2006-08-31 2017-08-29 Supernus Pharmaceuticals, Inc. Topiramate compositions and methods of enhancing its bioavailability
AU2007319141B2 (en) 2006-11-17 2013-01-10 Supernus Pharmaceuticals Inc. Sustained-release formulations of topiramate
CN102114002B (en) * 2006-12-04 2016-05-11 苏佩努斯制药公司 The immediate release formulation of the enhancing of Topiramate
US8071557B2 (en) * 2007-06-13 2011-12-06 Vivus, Inc. Treatment of pulmonary hypertension with carbonic anhydrase inhibitors
US20100198103A1 (en) 2007-10-09 2010-08-05 Imthera Medical, Inc. System and method for neural stimulation
BRPI0920548B8 (en) 2008-10-09 2021-06-22 Imthera Medical Inc device to control the position of a patient's tongue
BR112012010986A2 (en) 2009-11-10 2016-04-12 Imthera Medical Inc system to stimulate a hypoglossal nerve to control a patient's tongue position
JP2013516488A (en) * 2010-01-07 2013-05-13 バイバス・インコーポレイテッド Treatment of obstructive sleep apnea syndrome with a combination of carbonic anhydrase inhibitors and additional active agents
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
EP3179999A2 (en) * 2014-08-14 2017-06-21 Vivus, Inc. Treatment of sleep apnea with a combination of a carbonic anhydrase inhibitor and an aldosterone antagonist
BR112018068910A2 (en) 2016-05-11 2019-01-22 Hedner Jan sultiame for the treatment of sleep apnea

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US7056890B2 (en) * 1999-06-14 2006-06-06 Vivus, Inc. Combination therapy for effecting weight loss and treating obesity

Also Published As

Publication number Publication date
PT1261333E (en) 2005-09-30
CA2401000A1 (en) 2001-08-30
DE60111025T2 (en) 2006-05-04
DE60111025D1 (en) 2005-06-30
SE0000601D0 (en) 2000-02-24
AU2001232588B2 (en) 2004-04-22
JP4896334B2 (en) 2012-03-14
JP2003523384A (en) 2003-08-05
DK1261333T3 (en) 2005-08-29
AU3258801A (en) 2001-09-03
EP1261333B1 (en) 2005-05-25
US7981443B2 (en) 2011-07-19
US20040082519A1 (en) 2004-04-29
WO2001062243A1 (en) 2001-08-30
ES2243444T3 (en) 2005-12-01
CA2401000C (en) 2010-03-23
EP1261333A1 (en) 2002-12-04
NZ520781A (en) 2004-04-30

Similar Documents

Publication Publication Date Title
ATE296098T1 (en) USE OF TOPIRAMATE FOR THE TREATMENT AND DIAGNOSIS OF BREATHING DISORDERS DURING SLEEP AND MEANS OF CARRYING OUT TREATMENT AND DIAGNOSIS
DE69616376D1 (en) Use of tiagabin for the treatment of sleep disorders
ATE348808T1 (en) AZACYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF SEROTONIN RELATED DISEASES
ATE410163T1 (en) METHOD FOR THE TREATMENT AND DIAGNOSIS OF SLEEP BREATHING DISORDERS USING ZONISAMIDE AND MEANS FOR IMPLEMENTING THE METHOD
DE60227658D1 (en) METHOD FOR THE TREATMENT OF NEURODEEGENERATIVE, PSYCHIATRIC AND OTHER DISORDERS WITH DEACETYLASEINHIBITORS
ATE207351T1 (en) USE OF MODAFINIL TO TREAT SLEEPING RESPIRACY AND CENTRALLY EXCITED BREATHING DISCOMFORT
WO2002078644A3 (en) Use of ozone for the treatment of dental and oral conditions
NO20064964L (en) Treatment of impaired respiratory function
DE69333014D1 (en) USE OF 4-AMINOPYRIDINE FOR THE TREATMENT OF PAIN AND SPASTIC FOLLOWING INJURY TO THE BACKMARK
NO982989L (en) Use of inhibitors of the cellular Na + / H + exchanger (NHE) for the manufacture of a medicament for respiratory stimulation
DE59914712D1 (en) USE OF INHIBITORS OF THE KQT1 CHANNEL FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF DISEASES CAUSED BY HELMINTH AND ECOPOPARASITES
ATE301462T1 (en) USE OF REBOXETINE TO TREAT NEUROPSYCHIATRIC CONDITIONS
ATE191342T1 (en) USE OF RILUZOLE TO TREAT MITOCHONDRIAL DISEASES
DE69928521D1 (en) CABERGOLIN AND PRAMIPEXOL FOR THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM, IN PARTICULAR PARKINSON'S DISEASE
BR9908190A (en) Processes for treating female-specific pain in a female patient, and for treating chronic pain in a female patient
MX2023003258A (en) TREATMENT OF NF-κB-MEDIATED DISEASE.
DE69630055D1 (en) USE OF OLANZAPINE OR A SALT FOR THE PRODUCTION OF A MEDICINE FOR THE TREATMENT OF AUTISM AND MENTAL RETARDATION
ATE236630T1 (en) USE OF SCLAREOLIDS FOR THE TREATMENT OF EXCESSIVE CELL GROWTH DISEASES
BR0311180A (en) Methods for treating respiratory diseases and conditions using a selective inhibitor of inos
BRPI0415893A (en) methods for treating insomnia in a human patient in need of it, for treating primary insomnia in an adult or elderly human patient in need of it and for improving daytime functioning in a human patient in need, use of gaboxadol, and pharmaceutical composition
DE60024408D1 (en) USE OF TRICYCLIC ANTIDEPRESSIVA FOR THE TREATMENT OF HEADACHE
ATE239458T1 (en) USE OF SELEGILINE FOR THE TREATMENT OF EPILEPTIC DISEASES
SU950354A1 (en) Capral canal syndrome treatment method
DE60131100D1 (en) METHOD FOR THE TREATMENT OF CERTAIN EYE DISEASES
ATE291919T1 (en) USE OF ADATANSERIN FOR THE TREATMENT OF ACUTE NEURODEGENERATIVE DISEASES

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1261333

Country of ref document: EP